newsfilter
← Latest News
Business Wire·

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announces the appointment of Carlos Lopez as Senior Vice President, General